International Biotechnology Trust’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $9.4M | Sell |
216,000
-44,000
| -17% | -$1.92M | 3.17% | 10 |
|
|
2023
Q2 | $9.39M | Buy |
260,000
+16,000
| +7% | +$578K | 2.86% | 13 |
|
|
2023
Q1 | $9.07M | Hold |
244,000
| – | – | 2.53% | 14 |
|
|
2022
Q4 | $11.1M | Buy |
244,000
+108,000
| +79% | +$4.89M | 3.41% | 9 |
|
|
2022
Q3 | $9.5M | Buy |
136,000
+126,869
| +1,389% | +$8.86M | 3.05% | 11 |
|
|
2022
Q2 | $136K | Sell |
9,131
-179,369
| -95% | -$2.67M | 1.42% | 22 |
|
|
2022
Q1 | $1.37M | Buy |
188,500
+62,000
| +49% | +$452K | 0.31% | 50 |
|
|
2021
Q4 | $18.5M | Buy |
126,500
+28,000
| +28% | +$4.11M | 4.13% | 7 |
|
|
2021
Q3 | $17.4M | Buy |
98,500
+81,600
| +483% | +$14.4M | 4.2% | 8 |
|
|
2021
Q2 | $2.73M | Sell |
16,900
-50,500
| -75% | -$8.16M | 0.72% | 32 |
|
|
2021
Q1 | $11.5M | Hold |
67,400
| – | – | 3.05% | 14 |
|
|
2020
Q4 | $14.8M | Buy |
67,400
+40,500
| +151% | +$8.9M | 4.04% | 11 |
|
|
2020
Q3 | $4.46M | Sell |
26,900
-17,000
| -39% | -$2.82M | 1.44% | 21 |
|
|
2020
Q2 | $5.03M | Hold |
43,900
| – | – | 1.67% | 21 |
|
|
2020
Q1 | $3.37M | Buy |
43,900
+8,000
| +22% | +$615K | 1.54% | 17 |
|
|
2019
Q4 | $4.63M | Buy |
35,900
+25,000
| +229% | +$3.22M | 1.67% | 22 |
|
|
2019
Q3 | $849K | Hold |
10,900
| – | – | 0.39% | 44 |
|
|
2019
Q2 | $1.12M | Sell |
10,900
-10,800
| -50% | -$1.11M | 0.42% | 48 |
|
|
2019
Q1 | $1.59M | Buy |
+21,700
| New | +$1.59M | 0.59% | 45 |
|